Last updated on July 2018

Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)

Brief description of study

The purpose of this prospective, longitudinal, noninterventional study is to describe clinical characteristics, evolution of disease burden, and treatment patterns in patients with select subcategories of essential thrombocythemia (ET) or myelofibrosis (MF).

Clinical Study Identifier: NCT02953704

Contact Investigators or Research Sites near you

Start Over

MOST Study (Incyte Corporation)

Cape Girardeau, MO United States
  Connect »